WHO Drug Information Vol. 25, No. 2, 2011
WHO Drug Information Vol. 25, No. 2, 2011
WHO Drug Information Vol. 25, No. 2, 2011
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>WHO</strong> <strong>Drug</strong> <strong>Information</strong> <strong>Vol</strong>. <strong>25</strong>, <strong>No</strong>. 2, <strong>2011</strong> Proposed INN: List 105p. 165-166 samalizumabumsamalizumabsamalizumabsamalizumabreplace the description by the followingremplacer la description par la suivantesustitúyase el nombre químico por el siguienteimmunoglobulin G2/4-kappa, anti-[Homo sapiens CD200 (OX-2)], humanizedmonoclonal antibody;gamma2/4 heavy chain (1-442) [humanized VH (Homo sapiens IGHV1-69*01(73.50%) -(IGHD)-IGHJ4*01 L123>T (112), V124>L (113)) [8.8.10] (1-117) -Homo sapiens IGHG2*01 CH1-hinge-CH2 1.6-1.1 (118-232)- IGHG4*01 CH21-1<strong>25</strong>, CH3 1-129 K130>del (233-442)], (131-214')-disulfide with kappa lightchain (1'-214') [humanized V-KAPPA (Homo sapiens IGKV1-33*01 (81.10%) -IGKJ2*01 Q120>G (100)) [6.3.9] (1'-107') -Homo sapiens IGKC*01 (108'-214')];(219-219":220-220":223-223":226-226")-tetrakisdisulfide dimerimmunoglobuline G2/4-kappa, anti-[Homo sapiens CD200 (OX-2)], anticorpsmonoclonal humanisé;chaîne lourde gamma2/4 (1-442) [VH humanisé (Homo sapiens IGHV1-69*01(73.50%) -(IGHD)-IGHJ4*01 L123>T (112), V124>L (113)) [8.8.10] (1-117) -Homo sapiens IGHG2*01 CH1-charnière-CH2 1.6-1.1 (118-232)- IGHG4*01CH2 1-1<strong>25</strong>, CH3 1-129 K130>del (233-442)], (131-214')-disulfure avec lachaîne légère kappa (1'-214') [V-KAPPA humanisé (Homo sapiens IGKV1-33*01 (81.10%) -IGKJ2*01 Q120>G (100)) [6.3.9] (1'-107') -Homo sapiensIGKC*01 (108'-214')]; dimère (219-219":220-220":223-223":226-226")-tétrakisdisulfureinmunoglobulina G2/4-kappa, anti-[Homo sapiens CD200 (OX-2)], anticuerpomonoclonal humanizado;cadena pesada gamma2/4 (1-442) [humanizado VH (Homo sapiens IGHV1-69*01 (73.50%) - (IGHD)-IGHJ4*01 L123>T (112), V124>L (113)) [8.8.10] (1-117) -Homo sapiens IGHG2*01 CH1-bisagra-CH2 1.6-1.1 (118-232)-IGHG4*01 CH2 1-1<strong>25</strong>, CH3 1-129 K130>del (233-442)], (131-214')-disulfurocon la cadena ligera kappa (1'-214') [V-KAPPA humanizada(Homo sapiensIGKV1-33*01 (81.10%) -IGKJ2*01 Q120>G (100)) [6.3.9] (1'-107') -Homosapiens IGKC*01 (108'-214')]; dímero (219-219":220-220":223-223":226-226")-tetrakisdisulfurop. 168 delete/supprimer/suprimáse insert/insérer/insertesetasocitinibumtasocitinibtasocitinibtasocitinibtofacitinibumtofacitinibtofacitinibtofacitinibp. 179 vorapaxarumvorapaxarreplace the chemical name by the followingethyl [(1R,3aR,4aR,6R,8aR,9S,9aS)-9-{(1E)-2-[5-(3-fluorophenyl)pyridin-2-yl]ethen-1-yl}-1-methyl-3-oxododecahydronaphtho[2,3-c]furan-6-yl]carbamate203
Change language